U.S. IV INFUSION PRODUCTS MARKET ANALYSIS

U.S. IV Infusion Products Market, by Product Type (Cannulation (Needles and Catheter), IV Infusion Pump (Gravity Infusion Devices, Volumetric Pump, Syringe Pump, and Others), Infusion Lines (Set) (Gravity IV Set, Gravity IV Set W/Needle Free Connector, and Pump IV Set), and Others), by Stop Cock Type (3 Way Stopcock, Vacuum Stopcocks, Burette Stopcocks, and Others), by Needle Free Connector (Standalone Connectors and Needle-free Extension Sets), by Infusion Site (Peripheral IV, Medline IV, and Central IV), by Application (Pain Management, Antibiotic/Antiviral, Chemotherapy, and Others), and by End User (Ambulatory Surgical Centers, Clinics, Home Care Settings, Hospitals, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Published In : Oct 2021
Code : CMI4700
Pages :245
Formats :
Excel and PDF
Industry : Medical Devices

U.S. IV Infusion Products MarketSize and Trends

The increasing prevalence of chronic diseases is the major factor that is expected to drive growth of the U.S. IV infusion products market over the forecast period.

Figure 1: U.S. IV Infusion Products Market Share (%) Analysis, By Product Type, 2021

The increasing prevalence of chronic diseases is expected to drive growth of the U.S. IV infusion products market as the IV Infusion products are used for various purposes in chronic diseases such as blood transfusions, chemotherapy, and for administration of intravenous fluids and antibiotic. For instance, according to the article published by the National Health Council, U.S., in 2019, a chronic disease is defined as a disease, which lasts for three months or longer. According to the same source, around, 40 million of the U.S. population are suffering from one or the other chronic disease such as diabetes, heart disease, cancers, chronic lung diseases, stroke, Alzheimer\'s disease, chronic kidney disease, and others.